Category Archives: Food & Drug Recalls

Virtus Pharmaceuticals Opco II, LLC Issues Voluntary Nationwide Recall of Hyoscyamine sulfate Due to Superpotent and Subpotent Results

Virtus Pharmaceuticals Opco II, LLC (Virtus) is voluntarily recalling seven batches of Hyoscyamine sulfate (0.125mg) listed in the table below, to the consumer level which include the tablet, sublingual, and orally disintegrating
tablet form. This recall is being initiated due to both superpotent and subpotent test results. All of these batches were manufactured by Pharmatech LLC for
distribution by Virtus throughout the United States and Puerto Rico.

Drew’s, LLC Issues Allergy Alert on Undeclared Milk and Egg in One Lot of Field Day Organic Ranch Dressing

Drew’s, LLC of Chester, VT is voluntarily recalling one lot code of Field Day Organic Ranch Dressing due to product mislabeling that has resulted in an undeclared milk and egg allergen. Consumers who have severe allergies to milk and/or egg run the risk of serious or life- threatening allergic reaction if they consume this product.
Read The Complete Story!

Publix Recalls Apple Coffee Cakes (Foreign Matter-Metal)

Publix Super Markets of Lakeland, Florida, is issuing a voluntary recall for Apple Coffee Cakes due to the possible presence of small metal shavings. The Apple Coffee Cakes were sold at Publix bakery departments in Georgia, South Carolina, Alabama, Tennessee, North Carolina and the following counties in Florida: Alachua, Charlotte, Citrus, Collier, DeSoto, Hernando, Highlands, Hillsborough, Lee, Manatee, Marion, Pasco, Pinellas, Polk and Sarasota.

Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

Novo Nordisk Inc. is recalling six batches of the GlucaGen® HypoKit® in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile Water for Injection (SWFI). GlucaGen® HypoKit® is indicated for the treatment of severe hypoglycemia (low blood sugar) in patients with diabetes who are treated with insulin. A syringe with a detached needle cannot be used as prescribed.

FDA provides $21.8 million to states for FSMA produce safety rule implementation

The U.S. Food and Drug Administration today announced the awarding of a total of $21.8 million to support 42 states to help implement the FDA Food Safety Modernization Act (FSMA) produce safety rule. The rule, which the FDA finalized in November 2015, establishes science-based minimum standards for the safe growing, harvesting, packing and holding of fruits and vegetables grown for human consumption.